1. Targeting oxidative stress for the treatment of liver fibrosis
- Author
-
Luangmonkong, Theerut, Suriguga, Su, Mutsaers, Henricus A. M., Groothuis, Geny M. M., Olinga, Peter, Boersema, Miriam, Nilius, B, DeTombe, P, Gudermann, T, Jahn, R, Lill, R, Pharmaceutical Technology and Biopharmacy, Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Nanomedicine & Drug Targeting, and Groningen Institute for Organ Transplantation (GIOT)
- Subjects
0301 basic medicine ,MITOCHONDRIAL DYSFUNCTION ,Therapeutic target ,Liver fibrosis ,HEPATIC STELLATE CELLS ,medicine.disease_cause ,COENZYME-Q10 SUPPLEMENTATION ,DOUBLE-BLIND ,03 medical and health sciences ,Liver disease ,ENDOPLASMIC-RETICULUM STRESS ,TOLL-LIKE RECEPTOR ,NADPH OXIDASES ,medicine ,IN-VIVO ,Liver injury ,chemistry.chemical_classification ,Reactive oxygen species ,NADPH oxidase ,biology ,Chemistry ,Endoplasmic reticulum ,medicine.disease ,Cell biology ,030104 developmental biology ,Oxidative stress ,OXYGEN SPECIES PRODUCTION ,biology.protein ,Hepatic stellate cell ,EIF2-ALPHA DEPHOSPHORYLATION INHIBITOR ,Liver function - Abstract
Oxidative stress is a reflection of the imbalance between the production of reactive oxygen species (ROS) and the scavenging capacity of the antioxidant system. Excessive ROS, generated from various endogenous oxidative biochemical enzymes, interferes with the normal function of liver-specific cells and presumably plays a role in the pathogenesis of liver fibrosis. Once exposed to harmful stimuli, Kupffer cells (KC) are the main effectors responsible for the generation of ROS, which consequently affect hepatic stellate cells (HSC) and hepatocytes. ROS-activated HSC undergo a phenotypic switch and deposit an excessive amount of extracellular matrix that alters the normal liver architecture and negatively affects liver function. Additionally, ROS stimulate necrosis and apoptosis of hepatocytes, which causes liver injury and leads to the progression of end-stage liver disease. In this review, we overview the role of ROS in liver fibrosis and discuss the promising therapeutic interventions related to oxidative stress. Most importantly, novel drugs that directly target the molecular pathways responsible for ROS generation, namely, mitochondrial dysfunction inhibitors, endoplasmic reticulum stress inhibitors, NADPH oxidase (NOX) inhibitors, and Toll-like receptor (TLR)-affecting agents, are reviewed in detail. In addition, challenges for targeting oxidative stress in the management of liver fibrosis are discussed.
- Published
- 2018